Emerging role of interleukin-33 in autoimmune diseases

Pei, C., Barbour, M., Fairlie-Clarke, K. J., Allan, D., Mu, R. and Jiang, H.-R. (2014) Emerging role of interleukin-33 in autoimmune diseases. Immunology, 141(1), pp. 9-17. (doi: 10.1111/imm.12174) (PMID:24116703)

Full text not currently available from Enlighten.

Abstract

Interleukin-33 (IL-33) is a member of the IL-1 cytokine family. It predominantly induces type 2 immune responses and thus is protective against atherosclerosis and nematode infections but contributes to allergic airway inflammation. Interleukin-33 also plays a pivotal role in the development of many autoimmune diseases through mechanisms that are still not fully understood. In this review, we focus on the recent advances in understanding of the expression and function of IL-33 in some autoimmune disorders, aiming to provide insight into its potential role in disease development.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Fairlie-Clarke, Dr Karen and Jiang, Dr Hui-Rong
Authors: Pei, C., Barbour, M., Fairlie-Clarke, K. J., Allan, D., Mu, R., and Jiang, H.-R.
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
College of Medical Veterinary and Life Sciences > School of Biodiversity, One Health & Veterinary Medicine
Journal Name:Immunology
Publisher:Wiley
ISSN:0019-2805
ISSN (Online):1365-2567
Published Online:10 December 2013

University Staff: Request a correction | Enlighten Editors: Update this record